APC News
Full of sound and fury, signifying nothing
Novo Nordisk tried to convince the FDA that semaglutide injections are difficult to compound. (Spoiler: They aren't.)
October 25, 2024
Video: APC on Scripps
APC CEO Scott Brunner appeared on the Scripps News show “America On The Docket,” talking about the “brewing legal battle” over compounded tirzepatide and semaglutide.
October 18, 2024
BREAKING: FDA allows renewed compounding of tirzepatide copies — for now
In a win for continued patient access to compounded versions of Eli Lilly’s Mounjaro and Zepbound, FDA clarified today that pharmacies may continue to prepare copies of those FDA-approved drugs, at least for now.
October 18, 2024
FDA issues IV fluids emergency guidance
The FDA has published emergency guidance that empowers pharmacies to help address the nationwide IV solutions shortage.
October 17, 2024
The Journey to Earning the CPhT-Adv Certification from PTCB
Earning the Advanced Certified Pharmacy Technician Certification from the Pharmacy Technician Certification Board is a great way to boost your professional skills and career opportunities.
October 17, 2024
Earlier news
October 15, 2024
FDA reconsiders on tirzepatide, big questions remain
After a court order, the FDA agreed to reconsider taking tirzepatide off the shortage list.
October 11, 2024
Reporter briefing: Patient impacts of tirzepatide shortage resolution
APC's media briefing shared compounders' first-hand stories with more than 30 reporters from across the country.
October 11, 2024
Be sure your marketing follows these best practices
APC's new guide will help you stay on the right side of laws and regs.
October 11, 2024
A fake survey from a pharma-funded organization
What the Partnership for Safe Medicines released "Ain't a legitimate survey."
October 11, 2024
Lots of letters
On the compounding front, the FDA’s inbox is getting quite a workout lately.
October 11, 2024
Slick new dosing pen for compounders
Love Lifesciences’ UniPen injector pen is not only a Very Big Deal, it's available at a discount for APC PFM members.
October 2, 2024
FDA says tirzepatide shortage “resolved”
As of this afternoon, the FDA Drug Shortage List is showing that the shortage of tirzepatide injection is “resolved.” Pharmacies must immediately cease preparing and dispensing compounded copies of Mounjaro and Zepbound.
October 2, 2024
Get yer law and patient safety CE here
We've made the most popular segment of our 15-hour legal course into a standalone 3-hour, on-demand CE program.
October 2, 2024
Vet compounders: How has GFI 256 changed things?
Simply put, we want to know if you’ve been affected by recent FDA guidance on veterinary compounding.
September 27, 2024
Being a PFM just got better
APC is launching five new benefits for our Pharmacy-Facility members to help you and your business prosper.
September 27, 2024
Thompson elected, Browning appointed
Two changes to boards of directors were made last week.
September 20, 2024
HIPAA, schmipaa — Lilly is at it again
Now Eli Lilly is trying to "convince" people who have used compounded versions of tirzepatide to share their confidential medical records with the company.
